Home

CUONG V DO

CIK 1477037 · President & CEO · last filed 2026-08-28

CUONG V DO is a President & CEO who has filed 36 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing shows the insider bought $31.6K of BIVI on Aug 28, 2026. Across all open-market trades the lifetime net is +$56.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.6M across reported positions. 4 SEC filings were submitted jointly with Merck & Co., Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.65M

Companies

5

Total Filings

36

Lifetime Open-Market Net

$56.9K

Filer Profile

Reported Address
C/O BIOVIE
2120 COLORADO AVENUE, SUITE 230
SANTA MONICA, CA 90404
Related Filers
Merck & Co., Inc. — 4 joint filings, latest 2013-05-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIVI President & CEO 21,636 $1.93 $41.8K $49.4K 13 2026-08-28
ADAG Director 2,000 $3.40 $6.8K $7.5K 2 2026-08-18
BIVIW President & CEO 9,992 $0.35 $3.5K $0 2 2026-01-09
MRK EVP & Chief Strategy Officer — $143.93 — $0 3 2013-05-08
TEL SVP, Corp. Strategy & Bus. Dev 16,961 $211.96 $3.60M $0 13 2011-09-19

Recent Filings

36 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-28 BIVI Buy (P) +15,210 $31.6K EDGAR
2026-08-18 ADAG Buy (P) +2,000 $7.5K EDGAR
2026-08-17 ADAG Grant (A) — $0 EDGAR
2026-01-09 BIVIW Grant (A) — $0 EDGAR
2025-08-13 BIVIW Buy (P) +5,000 $0 EDGAR
2025-01-07 BIVI Grant (A) — $0 EDGAR
2024-07-12 BIVI Mixed +116,094 -$53.0K EDGAR
2024-03-06 BIVI Buy (P) +10,000 $0 EDGAR
2023-12-01 BIVI Buy (P) +10,000 $17.8K EDGAR
2023-07-03 BIVI Grant (A) +149,500 $0 EDGAR
Showing 1–10 of 36
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.